Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forward.
作者信息
Molina-Infante J, Gisbert J P
机构信息
Department of Gastroenterology, Hospital San Pedro de Alcantara, Caceres, Spain.
出版信息
Aliment Pharmacol Ther. 2013 Jul;38(2):204-5. doi: 10.1111/apt.12357.
PMID:23772902
Abstract
摘要
相似文献
1
Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forward.评论：通过幽门螺杆菌治疗克服抗生素耐药性——优化是前进的方向。
Aliment Pharmacol Ther. 2013 Jul;38(2):204-5. doi: 10.1111/apt.12357.
2
Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forward; authors' reply.
Aliment Pharmacol Ther. 2013 Jul;38(2):205-6. doi: 10.1111/apt.12367.
3
[Quadruple therapy is more effective against H. pylori].四联疗法对幽门螺杆菌更有效。
MMW Fortschr Med. 2016 May 12;158(9):20. doi: 10.1007/s15006-016-8178-0.
4
[Prevalence of resistance to antimicrobial agents of H. pylori].[幽门螺杆菌对抗菌药物的耐药率]
Arch Pediatr. 2010 Jun;17(6):816-7. doi: 10.1016/S0929-693X(10)70126-3.
5
6
[Update Helicobater pylori--what has changed?].[幽门螺杆菌的更新——有哪些变化？]
MMW Fortschr Med. 2012 Apr 19;154(7):99-101.
7
Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pylori.幽门螺杆菌治疗面临的挑战及根除的新视角
Dig Dis Sci. 2015 Oct;60(10):2901-12. doi: 10.1007/s10620-015-3712-y. Epub 2015 May 22.
8
Comparison table: Drugs for GERD and peptic ulcer disease.比较表：用于胃食管反流病和消化性溃疡病的药物。
Med Lett Drugs Ther. 2018 Jan 15;60(1538):e16-e18.
9
Drugs for GERD and peptic ulcer disease.用于治疗胃食管反流病和消化性溃疡病的药物。
Med Lett Drugs Ther. 2018 Jan 15;60(1538):9-16.
10
Eradication of : the power of nanosized formulations.消除：纳米制剂的威力。
Nanomedicine (Lond). 2020 Feb;15(5):527-542. doi: 10.2217/nnm-2019-0329. Epub 2020 Feb 7.
Zotero 插件